Enter your email address in the box to the right of this page to receive email updates from the Life Sciences Hub when new content is published.
For those with an interest in life sciences, the rise to prominence of CRISPR, a transformational development in the field of molecular biology and genetics, has been impossible to ignore.
Welcome to our blog dedicated to Life Sciences. We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector. We focus on (bio)pharmaceuticals and medical technologies, and also cover food and beverages, cosmetics and other healthcare products.
18 May 2020 - Posted by: Tine Carmeliet
On 3 April 2020, the Federal Agency for Medicines and Health Products (FAMHP) updated its guidelines on the labelling of medicinal products. The FAMHP stated in a communication that the update brought the guidelines in line with EU legislation and other national and international agreements. For example, to avoid medication errors, the guidance now includes › Read More
16 May 2020 - Posted by: Nieke Vanavermaete
In the fight against Covid-19 coronavirus, the Belgian government has taken several exceptional measures, including: Banning the use of rapid Covid-19 diagnostic tests for six months. Regulating the supply and distribution of essential medicines. Issuing guidelines for checking the compliance and suitability of surgical face masks. First, in order to avoid a misinterpretation of results, › Read More
15 May 2020 - Posted by: Eveline Van Keymeulen
Yesterday, Advocate General Tanchev presented his long-awaited opinion before the Court of Justice of the European Union (CJEU) in Case C-663/18 (Kanavape) stating that the general ban on natural cannabidiol (CBD) in France is contrary to EU law. It is the first time that the highest European Court, including the Advocate General, has been requested › Read More
14 May 2020 - Posted by: Laurie-Anne Ancenys
Laurie-Anne Ancenys, Counsel, Head of the Paris Tech & Data practice, and Juliette Olliveaud, Associate, look at how the ever-growing volume of data in our digital world presents both challenges and opportunities for patients and healthcare providers. The collection of vast sets of data and their subsequent valuation and monetisation has become a driving force › Read More
13 May 2020 - Posted by: Iradj Nazaryar
In March and April 2020, the Dutch Health and Youth Care Inspectorate (IGJ) announced various measures to mitigate the consequences of the Covid-19 coronavirus pandemic on the Dutch healthcare sector: Permission to supply medical devices that are not CE marked . Manufacturers and suppliers may temporarily supply medical devices without CE markings provided there are › Read More